Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,125,656
-$1,395,701 QoQ
Shares Held
129,803
-19.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#780
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $159,457,484 across 11 Drug Manufacturers - General names. PFE ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
182,419 | $45,903,917 | |
| 2 | AMGN |
Amgen Inc
|
103,528 | $37,489,559 | |
| 3 | JNJ |
Johnson & Johnson
|
132,112 | $33,552,484 | |
| 4 | LLY |
ELI LILLY & Co
|
11,114 | $13,330,466 | |
| 5 | MRK |
Merck & Co., Inc.
|
71,923 | $9,242,105 | |
| 6 | NVO |
Novo Nordisk A S
|
170,256 | $8,162,072 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
35,216 | $4,449,189 | |
| 8 | PFE |
Pfizer Inc
This page
|
129,803 | $3,125,656 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,125,656 | 129,803 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $4,521,357 | 161,017 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,848,295 | 154,550 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,115,794 | 43,791 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,161,847 | 47,931 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,401,960 | 55,326 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,267,311 | 47,769 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,999,515 | 103,646 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $3,078,499 | 110,025 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $4,089,961 | 147,386 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,898,972 | 135,428 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $6,194,265 | 186,743 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $7,402,390 | 201,810 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $7,759,466 | 190,183 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $12,089,770 | 235,944 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $9,948,748 | 227,348 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $11,865,800 | 226,317 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $11,183,924 | 216,031 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $11,700,462 | 198,145 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $8,334,520 | 193,781 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $7,334,746 | 187,302 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $6,036,062 | 166,604 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $6,510,216 | 176,860 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $6,234,516 | 169,878 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $5,767,272 | 176,369 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $5,844,608 | 179,063 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||